Table 1 Main characteristics of all studies included in the meta-analysis
| Â | Â | Â | Â | Â | C282Y | H63D | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Author | Year | Country | Study design | Cases/Controls | cases | controls | cases | controls | ||||||||
| Â | Â | Â | Â | Â | CC | CY | YY | CC | CY | YY | HH | HD | DD | HH | HD | DD |
Ezzkiouri | 2008 | Maroc | Case-control | 96/222 | 95 | 1 | 0 | 219 | 3 | 0 | 59 | 34 | 3 | 160 | 60 | 2 |
Nahon | 2008 | France | Cohort | 103/198 | 91 | 12 | 0 | 180 | 18 | 0 | 75 | 28 | 0 | 149 | 49 | 0 |
Repero | 2007 | Spain | Case-control | 196/181 | 183 | 12 | 1 | 158 | 23 | 0 | 102 | 85 | 9 | 124 | 52 | 5 |
Willis | 2005 | England | Case-control | 144/1508 | 119 | 17 | 8 | 1331 | 168 | 9 | Â | Â | Â | Â | Â | Â |
Hellerbrand | 2003 | Germany | Case-control | 137/233 | 120 | 17 | 0 | 223 | 10 | 0 | 108 | 27 | 2 | 177 | 52 | 4 |
Cauza | 2003 | Austria | Case-control | 162/671 | 139 | 18 | 5 | 603 | 63 | 5 | 128 | 31 | 3 | 529 | 133 | 9 |
Boige | 2003 | France | Case-control | 133/100 | 126 | 7 | 0 | 93 | 6 | 1 | 92 | 41 | 0 | 59 | 40 | 1 |
Lauret | 2002 | Spain | Case-control | 77/359 | 65 | 12 | 0 | 337 | 22 | 0 | 52 | 25 | 0 | 234 | 92 | 33 |
Beckman | 2000 | Sweden | Case-control | 54/294 | 43 | 10 | 1 | 255 | 38 | 1 | 37 | 17 | 0 | 229 | 59 | 6 |